Resolian appoints new leadership team in Malvern on October 29, 2024
- Rob Stachlewitz has been appointed as the new Chief Executive Officer of Resolian, while Pat Bennett transitions to Chief Business Officer and President of Scientific Affairs.
- The company has recently acquired multiple organizations, expanding its operations globally across four continents.
- This leadership reorganization is expected to enhance Resolian's growth and its ability to meet client and partner needs in the bioanalytical CRO sector.
On October 29, 2024, Resolian, a prominent bioanalytical contract research organization (CRO) based in Malvern, Pennsylvania, announced significant changes to its leadership team. Rob Stachlewitz will take over as CEO, while Pat Bennett, the current CEO, will assume the role of Chief Business Officer and President of Scientific Affairs. This shift in leadership marks a pivotal moment for the company as it navigates through its next phase of strategic growth. The reorganization aligns with Resolian's rapid expansion, which has been facilitated through notable acquisitions, including the takeover of Alliance Pharma, Inc. and Drug Development Solutions, as well as the establishment of a new bioanalytical laboratory in Brisbane, Australia. Most recently, the acquisition of Denali MedPharm in China has extended the company's operations to four continents, reflecting Resolian's commitment to becoming a global leader in bioanalytical services. As CEO, Rob Stachlewitz brings over 15 years of experience in pharmaceutical research and development from leading companies like Boehringer Ingelheim and Abbott Laboratories. Meanwhile, Pat Bennett will leverage his extensive background in bioanalytical sciences to enhance service capabilities and foster customer relationships in his new role. With these changes, Resolian aims to improve operational capacities and expand its market presence, ultimately strengthening its position in the competitive bioanalytical CRO industry. The leadership team, composed of Honggang Bi, Rob Stachlewitz, and Pat Bennett, combines a wealth of experience and expertise essential for guiding Resolian towards future innovation and growth.